Market revenue in 2023 | USD 4,229.5 million |
Market revenue in 2030 | USD 6,838.1 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Systemic coagulants |
Fastest growing segment | Systemic Coagulants |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Systemic Coagulants |
Key market players worldwide | Johnson & Johnson, Baxter International Inc, Pfizer Inc, Bristol-Myers Squibb Co, Sanofi SA, Bayer AG, Novo Nordisk A/S ADR, CSL Ltd, Octapharma AG, Grifols SA Ordinary Shares - Class A, Amgen Inc, Takeda Pharmaceutical Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account